🏛️ New York Crackdown • Ohio Hemp Pivot • Federal Cases Advance

Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.

New York’s move against Omnium Health marks a turning point for how states police brand partnerships and white-label deals, while Ohio lawmakers pivot from cannabis restrictions to a hemp crackdown that could reshape national supply chains. Add a Supreme Court case testing whether cannabis use strips constitutional rights, and this week’s theme is clear: the lines between enforcement, compliance, and politics are blurring faster than ever.

Today’s edition is brought to you by Contrarian Thinking, Guru Conference, and 1440 Media. A new episode of The Hybrid dropped last week with Pamela Epstein of Terpene Belt, explores hemp’s high-stakes future and the policy gaps regulators still haven’t solved. We have more exciting guests coming, too.

Read the stories. Support the journalists covering this beat. Hire experts who track these markets every day. The rules are changing - and so are the risks.

🏛️ New York cracks down on unlicensed brand deals
🌿 Ohio pivots from cannabis limits to hemp restrictions
⚖️ Supreme Court takes up cannabis gun rights case

Start informed. Stay ready.

📌 What Happened: New York's Office of Cannabis Management filed administrative charges Monday seeking to revoke Omnium Health's manufacturing and distribution licenses, impose at least $1 million in fines, and ban the Long Island processor from the state for allowing unlicensed out-of-state brands to manufacture products at its facilities without obtaining required Type 3 Brand Licenses. The charges followed an eight-month investigation showing Omnium collected rent and royalties from brands including Stiiizy, Mfused, and Grön while passing off their manufacturing as its own work, bypassing New York's requirement that even brands using white-label arrangements must become licensed. OCM ordered a $30 million recall of products made at Omnium facilities and said the investigation remains active with additional cases potentially filed against the brands that used the scheme. Between January and August, the 17 brands using Omnium's unlicensed arrangement generated $65 million in sales representing 6.2 percent of New York's $1 billion market, with most products already sold to consumers during the 4/20 rush before regulators moved. State law allows penalties of three to five times retail value of products, which could produce fines far exceeding the proposed $1 million baseline and set a record for the agency.

💡 Why It Matters: Legitimate business practices like co-packing and white labeling just became compliance minefields where paperwork determines legality rather than product safety. New York created the Type 3 Brand License specifically to allow out-of-state brands to license their IP and enter white-label agreements with New York processors without becoming True Parties of Interest or operating facilities, recognizing that co-packing is standard industry practice. The violation here was operating without that license, but the compliance line is razor-thin: brands licensing IP while attempting to avoid individual licensure state-by-state can easily cross from permitted white labeling into prohibited reverse licensing depending on contract structure and control provisions. Regulators can spot this through batch records and equipment capacity analysis, but proving it in administrative hearings when brands claim compliant white-label agreements is considerably harder. OCM saying products were likely safe despite Omnium's inability to provide complete manufacturing records means enforcement is about market structure protection rather than consumer safety. Interstate commerce would eliminate these gymnastics entirely, but federal prohibition forces brands into state-by-state licensing arrangements that create grey areas sophisticated operators exploit.

🔄 Ohio House to Gut Cannabis Restrictions, Target Hemp Market Instead

Ohio lawmakers are amending legislation to remove controversial cannabis rollbacks like halving home grow limits while inserting a temporary ban on intoxicating hemp products except THC beverages sold through stores and breweries. Representative Jamie Callender admitted the legislative strategy is to force Senate acceptance of cannabis provisions by bundling them with hemp restrictions the governor demanded after his executive order banning intoxicating hemp was blocked by a judge. Speaker Matt Huffman acknowledged prohibitionists have lost the cannabis debate within the Republican caucus, but hemp becomes the compromise target to claim they addressed youth access concerns without further restricting the voter-approved adult-use market. The U.S. Hemp Roundtable is warning the proposal would severely limit retail access by creating a hemp dispensary model, killing the gas station and convenience store channels that currently dominate sales. The beverage carveout is actually the smart policy choice: age-gated liquor stores can responsibly sell hemp drinks that don't compete well in dispensaries anyway, while killing the unregulated gas station gummies and vapes that give hemp a bad name and create legitimate youth access concerns the cannabis industry shares. (Marijuana Moment)

🗳️ Massachusetts Ballot Campaign Seeks to End Adult-Use Cannabis Market

The Coalition for Safe Communities collected over 27,000 signatures for a 2026 ballot measure that would repeal Massachusetts' adult-use cannabis law while keeping medical cannabis intact, and they need roughly 75,000 certified signatures to qualify. The campaign claims legalization increased youth use and impaired driving, though state data shows teen cannabis use has actually declined since 2016 and roadside testing remains scientifically unreliable. If this qualifies for the ballot, every institutional investor and multi-state operator will pause Massachusetts expansion plans for 18 months while the outcome remains uncertain, and uncertainty kills capital faster than actual policy changes. Well-funded prohibition groups are testing whether voter remorse plays in mature markets, and if Massachusetts looks vulnerable expect similar efforts in Nevada, Michigan, and other states where legalization passed narrowly. Public sentiment in Massachusetts has likely shifted more pro-legalization since implementation, not less, but the industry isn't flush with cash to fend off a well-funded repeal campaign. The industry has organic infrastructure in employees, customers, and public officials who benefit from tax revenue, but they'll need to actually organize and coordinate those assets while groups like SAM can create ballot campaigns with murky donations and no accountability to local stakeholders. (Cannabis Business Times)

⏱️ Rhode Island Retail Licenses May Not Be Ready Until May 2026

Rhode Island's Cannabis Control Commission voted to adopt a timeline that won't award the state's 24 retail licenses until May 2026 at earliest, with a 90-day application review starting in January plus 60 additional days for applicants to secure local zoning approvals after the December 29th application deadline. Early applicants who already secured compliant locations and paid rent for months are furious that the commission is allowing competitors extra time to obtain zoning permits, with one commissioner voting against the timeline arguing it penalizes better-prepared businesses. The commission justified the delay partly because it was slow rolling out social equity certification, receiving 94 applications for six social equity licenses but only opening that screening process in August with a September deadline. Rhode Island legalized adult-use cannabis in May 2022 but new retail licenses won't be issued until four years after legalization, and even May 2026 assumes the commission can review applications quickly despite having received zero submissions yet and acknowledging thousands of applications could delay everything further. Small states with limited regulatory staff cannot compress licensing timelines no matter how loudly the industry complains, and applicants banking on 2026 openings should prepare for 2027 reality when municipalities challenge approvals and buildouts take longer than projected. (News From The States)

⏰ Senator Wyden Calls Trump Rescheduling Delay "Extremely Concerning"

Senator Ron Wyden told Marijuana Moment that Trump delaying cannabis rescheduling two months after promising August action is "extremely concerning" and perpetuates injustices of the failed drug war. Trump pledged during the campaign to support moving cannabis to Schedule 3 and protect state programs, but the administration has been silent since taking office while the DEA review remains stalled. Trump has zero incentive to spend political capital on rescheduling when he already captured cannabis voter support with campaign promises, and waiting until closer to 2026 midterms gives him a fresh talking point when he actually needs it. Wyden's criticism reveals Democratic strategy: frame any Trump inaction as broken promises to peel off libertarian-leaning voters who backed him specifically on cannabis reform. Every month of delay increases the chances this becomes a 2026 campaign issue rather than a 2025 policy achievement, so operators should plan business models around Schedule 1 restrictions lasting at least another 18 months regardless of what politicians promise. (Marijuana Moment)

⚖️ Supreme Court to Rule on Drug User Gun Ban

The Supreme Court will decide whether federal law prohibiting drug users from possessing firearms violates the Second Amendment, taking a case where the Fifth Circuit ruled the ban unconstitutional as applied to marijuana users in legal states. The case forces the Court to reconcile its expansive Second Amendment rulings with federal insistence that all cannabis use remains criminal and disqualifying, affecting millions of Americans in legal states who have been forced to choose between state-legal medicine and constitutional rights. The Fifth Circuit decision was inevitable once Bruen established gun regulations must match historical tradition, and there is no founding-era precedent for disarming people who consumed substances that were widely used medicinally. The Court cannot dodge the core question: either cannabis use is dangerous enough to strip constitutional rights, or federal prohibition has become so detached from reality it cannot support derivative restrictions. A ruling acknowledging state-legal cannabis users retain constitutional rights backs federal agencies into a corner to explain why these same individuals remain criminals under the Controlled Substances Act, turning cannabis policy contradictions into constitutional problems rather than political ones courts can ignore. (Bloomberg Law)

🗳️ Virginia Election Could Determine Whether Retail Cannabis Market Finally Launches

Virginia's November 4th gubernatorial election will likely determine whether the state implements a retail cannabis market after four years of legal possession without legal sales, with Republican candidate Winsome Earle-Sears opposing adult-use cannabis and Democrat Abigail Spanberger supporting regulated retail. Governor Glenn Youngkin vetoed retail market legislation earlier this year claiming it failed to protect children and eliminate black markets, forcing Virginians to continue buying from illicit sellers despite adult-use being legal since 2021. VCU researchers testified to a joint legislative commission that unregulated shops are selling untested cannabis products containing fecal contamination and mislabeled contents, proving Youngkin's veto achieved the opposite of his stated goals by keeping consumers in dangerous unregulated channels. The commission will review transition legislation in December before the General Assembly convenes January 14th, but if Earle-Sears wins she would likely veto any retail bill just as Youngkin did. Virginia's absurdity: possession is legal but sales are not, creating a permanent illicit market that prohibition governors point to as justification for continued prohibition while operators who spent years preparing for licenses watch the market opportunity vanish. (The Virginian-Pilot)

⚖️ Florida Medical Marijuana Licensing Hearing Could Run Through February

Florida's months-long administrative hearing over 22 medical marijuana licenses began Monday with 13 rejected applicants challenging their scores before Administrative Law Judge Mary Creasy, with the hearing slated to run through mid-February before any licenses are actually awarded. The Department of Health announced intent to award licenses in November 2024 after receiving 72 applications in April 2023, and the hearing timeline suggests licenses won't be issued until mid-2026 at earliest assuming no appeals. One rejected applicant scored only 23 points below the lowest selected applicant and received five out of 60 points on cultivation despite demonstrating they had already secured significant infrastructure and equipment, highlighting how arbitrary merit-based scoring becomes in practice. Another high-scoring applicant was disqualified for allegedly failing to name every natural person affiliated with the application, showing how technical compliance requirements can override substantive qualifications. The 2017 law requiring new licenses as patient counts increased has taken eight years to produce actual licenses, and applicants who bet on the failed 2024 legalization amendment creating immediate market value are now stuck maintaining investor commitments through years of administrative procedure before earning any revenue. (WUSF)

🏝️ Virgin Islands Issues First Cannabis Licenses After Three-Year Delay

The U.S. Virgin Islands Office of Cannabis Regulation issued licenses to 13 cultivators last week and opened manufacturing applications through December 19th, nearly three years after legalizing adult-use cannabis in January 2023. The territory requires majority ownership by residents who lived there 10 of the last 15 years or attended Virgin Islands schools for five years, creating one of the strictest residency requirements in any U.S. cannabis market. Three years from legalization to licensing is what happens when legislators pass cannabis laws without funding regulatory buildout or understanding how long merit-based reviews actually take. Virgin Islands regulators are still reviewing dispensary applications, so the territory legalized in 2023 but won't have functioning retail until late 2025 at earliest, leaving residents in legal limbo while the illicit market consolidated. Nebraska and North Carolina just legalized and will hit the same timeline: voter approval in 2024, first licenses in 2027 if they're lucky, retail sales in 2028 if municipalities cooperate and buildouts don't stall. (MJBiz Daily)